These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27435198)

  • 21. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate.
    Higashi K; Hayashi H; Yamamoto K; Moribe K
    Int J Pharm; 2015 Oct; 494(1):9-16. PubMed ID: 26253374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
    Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
    Colloids Surf B Biointerfaces; 2017 Jun; 154():89-95. PubMed ID: 28324691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.
    Cheney ML; Weyna DR; Shan N; Hanna M; Wojtas L; Zaworotko MJ
    J Pharm Sci; 2011 Jun; 100(6):2172-81. PubMed ID: 21491441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
    S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
    Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats.
    Nielsen LH; Rades T; Müllertz A
    Int J Pharm; 2015 Jul; 490(1-2):334-40. PubMed ID: 26026252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Particle engineering/different film approaches for earlier absorption of meloxicam.
    Farid M; El-Setouhy DA; El-Nabarawi MA; El-Bayomi T
    Drug Deliv; 2016 Sep; 23(7):2309-2317. PubMed ID: 25431841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved absorption of meloxicam via salt formation with ethanolamines.
    Han HK; Choi HK
    Eur J Pharm Biopharm; 2007 Jan; 65(1):99-103. PubMed ID: 16919925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
    Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
    Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
    Aghazadeh-Habashi A; Jamali F
    Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.
    Noolkar SB; Jadhav NR; Bhende SA; Killedar SG
    AAPS PharmSciTech; 2013 Jun; 14(2):569-77. PubMed ID: 23483432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000.
    Vijaya Kumar SG; Mishra DN
    Yakugaku Zasshi; 2006 Aug; 126(8):657-64. PubMed ID: 16880724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
    Haser A; Cao T; Lubach JW; Zhang F
    Mol Pharm; 2018 Mar; 15(3):1226-1237. PubMed ID: 29412681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of co-spray-dried meloxicam-mannitol systems containing crystalline microcomposites.
    Pomázi A; Ambrus R; Sipos P; Szabó-Révész P
    J Pharm Biomed Anal; 2011 Sep; 56(2):183-90. PubMed ID: 21652159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
    Salmani JM; Lv H; Asghar S; Zhou J
    Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
    J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of meloxicam in situ implant formulation by quality by design principle.
    Ibrahim HM; Ahmed TA; Hussain MD; Rahman Z; Samy AM; Kaseem AA; Nutan MT
    Drug Dev Ind Pharm; 2014 Jan; 40(1):66-73. PubMed ID: 23298324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.